000			01948nam a2200277Ia 4500
003			MX-MdCICY
005			20250625140641.0
040			_cCICY
090			_aB-10969
245	1	0	_aTumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
490	0		_vJournal of Controlled Release, 65(1-2), p.271-284, 2000
520	3		_aMost solid tumors possess unique pathophysiological characteristics that are not observed in normal tissues or organs, such as extensive angiogenesis and hence hypervasculature, defective vascular architecture, impaired lymphatic drainage / recovery system, and greatly increased production of a number of permeability mediators. The phenomenon now known as the enhanced permeability and retention (EPR)effect for lipid and macromolecular agents has been observed to be universal in solid tumors. Primarily, enhanced vascular permeability will sustain an adequate supply of nutrients and oxygen for rapid tumor growth. The EPR effect also provides a great opportunity for more selective targeting of lipid- or polymer-conjugated anticancer drugs, such as SMANCS and PK-1, to the tumor. In the present review, the basic characteristics of the EPR effect, particularly the factors involved, are described, as well as its modulation for improving delivery of macromolecular drugs to the tumor. Tumor-specific vascular physiology is also described.
650	1	4	_aTUMOR VASCULAR PERMEABILITY
650	1	4	_aEPR EFFECT
650	1	4	_aMACROMOLECULAR THERAPEUTICS
650	1	4	_aPERMEABILITY FACTORS
650	1	4	_aTUMOR TARGETING
700	1	2	_aMaeda, H.
700	1	2	_aWu, J.
700	1	2	_aSawa, T.
700	1	2	_aMatsumura, Y.
700	1	2	_aHori, K.
856	4	0	_uhttps://drive.google.com/file/d/1ZMHxgdwbCZGo3rIo8NJopdK_GX_x0a8A/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c45200 _d45200